The estimated Net Worth of Renee D Gala is at least $7.33 Milion dollars as of 18 May 2023. Ms Gala owns over 6,000 units of Jazz Pharmaceuticals plc stock worth over $3,782,367 and over the last 10 years she sold JAZZ stock worth over $2,626,875. In addition, she makes $924,520 as Exec. VP & CFO at Jazz Pharmaceuticals plc.
Ms has made over 6 trades of the Jazz Pharmaceuticals plc stock since 2015, according to the Form 4 filled with the SEC. Most recently she sold 6,000 units of JAZZ stock worth $790,500 on 18 May 2023.
The largest trade she's ever made was selling 43,743 units of Jazz Pharmaceuticals plc stock on 14 August 2018 worth over $1,171,875. On average, Ms trades about 1,753 units every 60 days since 2014. As of 18 May 2023 she still owns at least 35,978 units of Jazz Pharmaceuticals plc stock.
You can see the complete history of Ms Gala stock trades at the bottom of the page.
Renee D. Gala is the Exec. VP & CFO at Jazz Pharmaceuticals plc.
As the Exec. VP & CFO of Jazz Pharmaceuticals plc, the total compensation of Ms Gala at Jazz Pharmaceuticals plc is $924,520. There are 8 executives at Jazz Pharmaceuticals plc getting paid more, with Bruce Cozadd having the highest compensation of $14,713,600.
Ms Gala is 49, she's been the Exec. VP & CFO of Jazz Pharmaceuticals plc since . There are 24 older and 3 younger executives at Jazz Pharmaceuticals plc. The oldest executive at Jazz Pharmaceuticals plc is Catherine Sohn, 67, who is the Independent Director.
Renee's mailing address filed with the SEC is 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, L2, .
Over the last 17 years, insiders at Jazz Pharmaceuticals plc have traded over $1,513,676,247 worth of Jazz Pharmaceuticals plc stock and bought 1,319,315 units worth $25,188,964 . The most active insiders traders include Michael W Michelson, Patrick G Enright a Jp Iii Llckkr Partners Iii,.... On average, Jazz Pharmaceuticals plc executives and independent directors trade stock every 11 days with the average trade being worth of $5,162,934. The most recent stock trade was executed by Mary Elizabeth Henderson on 6 September 2024, trading 1,410 units of JAZZ stock currently worth $152,703.
jazz pharmaceuticals plc (nasdaq: jazz) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. we are a diverse company of over 875 employees focused on portfolio of products and/or product candidates in the areas of sleep, hematology/oncology and pain. founded in 2003 and headquartered in dublin, ireland, jazz pharmaceuticals has u.s. offices in palo alto, ca and philadelphia, pa, and has offices in various other locations in europe. the company’s maintains a highly collaborative and entrepreneurial culture where employees focus on how they accomplish success as well as what is done to accomplish results by operating in accordance with the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. we plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our uni
Jazz Pharmaceuticals plc executives and other stock owners filed with the SEC include: